Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1979 1
1985 1
1986 1
1988 2
1989 1
1990 1
1992 1
1995 1
1996 2
1997 2
1998 5
1999 2
2000 5
2001 4
2002 3
2003 4
2004 2
2005 2
2006 5
2007 5
2008 6
2009 9
2010 8
2011 4
2012 5
2013 9
2014 8
2015 3
2016 6
2017 7
2018 11
2019 13
2020 6
2021 12
2022 14
2023 9
2024 9
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.
Werth VP, Joly P, Mimouni D, Maverakis E, Caux F, Lehane P, Gearhart L, Kapre A, Pordeli P, Chen DM; PEMPHIX Study Group. Werth VP, et al. N Engl J Med. 2021 Jun 17;384(24):2295-2305. doi: 10.1056/NEJMoa2028564. Epub 2021 May 19. N Engl J Med. 2021. PMID: 34097368 Clinical Trial.
Oral Hairy Leukoplakia.
Karakioulaki M, Schauer F. Karakioulaki M, et al. Among authors: schauer f. N Engl J Med. 2024 Dec 19;391(24):2360. doi: 10.1056/NEJMicm2410115. Epub 2024 Dec 14. N Engl J Med. 2024. PMID: 39680647 No abstract available.
Plectin in Skin Fragility Disorders.
Kiritsi D, Tsakiris L, Schauer F. Kiritsi D, et al. Among authors: schauer f. Cells. 2021 Oct 14;10(10):2738. doi: 10.3390/cells10102738. Cells. 2021. PMID: 34685719 Free PMC article. Review.
[Autoimmune blistering dermatoses in children].
Kiritsi D, Schauer F. Kiritsi D, et al. Among authors: schauer f. Hautarzt. 2019 Apr;70(4):277-282. doi: 10.1007/s00105-019-4379-7. Hautarzt. 2019. PMID: 30941468 Review. German.
The gut microbiome in bullous pemphigoid: implications of the gut-skin axis for disease susceptibility.
Liu X, van Beek N, Cepic A, Andreani NA, Chung CJ, Hermes BM, Yilmaz K, Benoit S, Drenovska K, Gerdes S, Gläser R, Goebeler M, Günther C, von Georg A, Hammers CM, Holtsche MM, Hübner F, Kiritsi D, Schauer F, Linnenmann B, Huilaja L, Tasanen-Määttä K, Vassileva S, Zillikens D, Sadik CD, Schmidt E, Ibrahim S, Baines JF. Liu X, et al. Among authors: schauer f. Front Immunol. 2023 Nov 10;14:1212551. doi: 10.3389/fimmu.2023.1212551. eCollection 2023. Front Immunol. 2023. PMID: 38022583 Free PMC article.
Native Autoantigen Complex Detects Pemphigoid Autoantibodies.
Mai S, Izumi K, Mai Y, Natsuga K, Ishii N, Sawamura D, Schauer F, Kiritsi D, Nishie W, Ujiie H. Mai S, et al. Among authors: schauer f. JID Innov. 2023 Feb 20;3(3):100193. doi: 10.1016/j.xjidi.2023.100193. eCollection 2023 May. JID Innov. 2023. PMID: 36992950 Free PMC article.
Oral Hairy Leukoplakia. Reply.
Karakioulaki M, Schauer F. Karakioulaki M, et al. Among authors: schauer f. N Engl J Med. 2025 Jun 5;392(21):2182. doi: 10.1056/NEJMc2504743. N Engl J Med. 2025. PMID: 40466084 No abstract available.
Safety, tolerability, pharmacokinetics, and pharmacodynamic effects of desmoglein 3-peptide-coupled tolerizing nanoparticles in pemphigus.
Didona D, Hudemann C, Garn H, Krzikalla D, Wang SH, Hinterseher J, Volkmann K, Polakova A, Zakrzewicz A, Feldhoff S, Tikkanen R, Digigow R, Pfützner W, Santos A, Zimmer CL, Hahmann M, Harnisch S, Rösch S, Huguenin S, Eming R, Hahn M, Schauer F, Antiga E, Senatore S, Maglie R, Täubel J, Ghoreschi K, Meier K, Solimani F, Sticherling M, Sollfrank L, Günther C, Steinbrink K, Magnolo N, van Schaick E, Asnaghi V, Zollmann FS, Pohlner J, Hummel J, Sandbrink R, de Min C, Fleischer S, Möbs C, Hertl M. Didona D, et al. Among authors: schauer f. Br J Dermatol. 2025 Aug 7:ljaf311. doi: 10.1093/bjd/ljaf311. Online ahead of print. Br J Dermatol. 2025. PMID: 40795222
Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trial.
Kiritsi D, Schauer F, Gewert S, Reineker K, Reimer-Taschenbrecker A, Schwieger-Briel A, Ott H, Schmoor C, Grishina O, Murrell D, Stiller B, Zahn T, Nyström A, Bruckner-Tuderman L. Kiritsi D, et al. Among authors: schauer f. EClinicalMedicine. 2024 Oct 30;77:102900. doi: 10.1016/j.eclinm.2024.102900. eCollection 2024 Nov. EClinicalMedicine. 2024. PMID: 39539991 Free PMC article.
180 results